Brian A Davis
Insider
First SEC filing: Dec. 20, 2023 · Latest: Dec. 20, 2023
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 17, 2026 | GRCE | A | None | · | · | 12,200 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 8, 2026 | GRCE | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 9, 2025 | GRCE | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 19, 2023 | GRCE | A | 22,500 | · | · | 22,500 Direct | · | Acquired | (price as of 2026-10-02) |
| June 4, 2021 | VRCA | P | 5,000 | $9.89 | $49,450 | 12,900 Direct | +63.29% | Acquired | -95.6% (price as of 2026-10-02) |
| March 1, 2021 | VRCA | A | 65,000 | · | · | 65,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 13, 2020 | VRCA | P | 7,900 | $6.24 | $49,296 | 7,900 Direct | · | Acquired | -93.0% (price as of 2026-10-02) |
| Feb. 27, 2020 | VRCA | A | 55,000 | · | · | 55,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 18, 2019 | VRCA | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 17, 2026 | GRCE | Stock Option (Right to Buy) | Common Stock | $2.13 | Sept. 16, 2036 | · | Acquired |
| Jan. 8, 2026 | GRCE | Stock Option (Right to Buy) | Common Stock | $3.80 | Jan. 8, 2036 | 10,000 | Acquired |
| May 9, 2025 | GRCE | Stock Option (Right to Buy) | Common Stock | $2.72 | May 9, 2035 | 10,000 | Acquired |
| Dec. 19, 2023 | GRCE | Stock Options (Right to Buy) | Class A Common Shares | $2.12 | Dec. 19, 2033 | 22,500 | Acquired |
| March 1, 2021 | VRCA | Employee Stock Option (Right to Buy) | Common Stock | $14.32 | Feb. 28, 2031 | 65,000 | Acquired |
| Feb. 27, 2020 | VRCA | Employee Stock Option (Right to Buy) | Common Stock | $11.81 | Feb. 26, 2030 | 55,000 | Acquired |
| Oct. 18, 2019 | VRCA | Stock Option (Right to Buy) | Common Stock | $14.65 | Oct. 18, 2029 | 125,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | · | · | · | $4,315,771,227,500 | $12,420,030,822 | · | $638,334,336 | $10,077,351,339,581 |
| 2019 | $76,923 | · | · | · | $30,822 | · | $4,336 | $1,339,581 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.